SCHEMBL13359372

SCHEMBL13359372

CC1C(N2CCN(C)CC2)c2ccccc2Sc2cccn21

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 1/20 0.45
HTR7 P34969 3/20 0.42
DRD2 P14416 7/20 0.41
HTR2A P28223 2/20 0.41
DRD3 P35462 1/20 0.41
HRH1 P35367 3/20 0.40
HTR2C P28335 3/20 0.40
DRD4 P21917 2/20 0.40
TP53 P04637 2/20 0.40
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2D6 P10635 2/20 0.40
CYP2C19 P33261 2/20 0.40
NPC1 O15118 2/20 0.40
MTOR P42345 2/20 0.40
RAB9A P51151 2/20 0.40
TSHR P16473 1/20 0.40
NFKB1 P19838 1/20 0.40
THPO P40225 1/20 0.40
HIF1A Q16665 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13359374 0.84 SLC6A3 (0.62) SLC6A3DRD2HRH1HTR2CDRD4
SCHEMBL14393845 0.81 BLM (0.40) NPC1RAB9AMAPTSMN1; SMN2HTT
SCHEMBL13359376 0.80 POLB (0.47) CYP2C19TSHRMAPTSMN1; SMN2ALDH1A1
SCHEMBL7494352 0.75 SLC6A3 (0.74) SLC6A3HTR7DRD2HRH1HTR2C
SCHEMBL14393844 0.68 SLC6A3 (0.45) SLC6A3DRD2HRH1HTR2CDRD4
SCHEMBL3837897 0.67 DRD2 (0.75) HTR7DRD2HTR2AHRH1HTR2C
SCHEMBL29414105 0.67 DRD2 (0.75) HTR7DRD2HTR2AHRH1HTR2C
SCHEMBL6208534 0.67 SLC6A3 (0.41) SLC6A3HTR7DRD2HTR2ADRD3
SCHEMBL13359371 0.67 SLC6A3 (0.43) SLC6A3CYP1A2CYP2C19TSHRMAPT
SCHEMBL10863193 0.62 ALDH1A1 (0.47) HTR7DRD2HTR2ADRD3HRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7713956-B2 Dealkylated derivatives of pyrrolo[2,1-b]benzothiazepines with atypical antipsychotic activity SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2010-05-11 US disclosed
US-20070270402-A1 Dealkylated Derivatives of Pyrrolo[2,1-B]Benzothiazepines with Atypical Antipsy-Chotic Activity SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2007-11-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070270402-A1 Dealkylated Derivatives of Pyrrolo[2,1-B]Benzothiazepines with Atypical Antipsy-Chotic Activity CNR1, HRH4, CNR2 SLC6A3 405/4885HTR7 184/4885DRD2 16/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.